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Abstract
A retrospective case note review was con- 
ducted of 47 patients o f 15 years and older 
who had sustained simple partial status 
epilepticus (SPSE) in The Netherlands 
between 1980 and 1987. In 46 patients the 
type of SPSE was somatomotor (in four 
adversive)5 and in one aphasic with visual 
and auditory hallucinations. SPSE was 
more common over the age of 50, Six of 27 
patients with previous epilepsy had an 
acute symptomatic cause. In 20 patients 
without previous epilepsy stroke was the 
most frequent cause (75%)* Outcome was 
determined by the underlying cause* In 
one patient the continuing epileptic activ­
ity may have caused neuronal damage.
(J Neurol Ncuwsurg Psychiatry 1996;61:00-92)
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Simple partial status epilepticus (SPSE) is 
characterised by partial seizures without 
impairment of consciousness or secondary 
generalisation^ and with preserved neurovege- 
tative regulation.1 The clinical expression 
depends on the region of the brain where the 
seizures originate.The most frequent type of 
SPSE is somatomotor. Other types include 
aphasic and somatosensory SPSE. Partial 
seizures with preserved consciousness are 
called SPSE when continuous clinical and 
EEG seizures are present for at least 30 min­
utes.2
In general neurological practice two groups 
of patients widi SPSE are encountered most 
often:
(1) Those with a succession of simple par­
tial seizures with Jacksonian march., without 
persistent segmental myoclonus (somatomotor 
SPSE),
(2) Those with persistent myoclonus in a 
limited area of the body^ present for weeks or 
months and sometimes in combination with 
somatomotor or tonic-clonic seizures (epilep­
sia partialis continua> EPC). Consciousness 
may be normal but can also be impaired.
Both types are usually caused by a sympto­
matic brain lesion, but may also occur in 
patients with a history of epilepsy.
Somatomotor SPSE is synonymous with 
EPC when myoclonic jerks are continuously 
present in the same body parts affected by the 
somatomotor seizures.2 4 Most case studies or 
reviews concern EPC; other types of SPSE 
have only rarely been described; 1 H As part of a 
study on status epilepticus in The Netherlands 
we were able to study retrospectively 47 adult 
patients with SPSE. We were particularly 
interested in the various types of SPSE, the 
causes, EEG findings3 treatment, and out­
come.
Methods
The cooperation of neurologists in 50 different 
hospitals in The Netherlands was requested. 
Fourteen agreed to cooperate, but two were 
unable to provide adequate documentation of 
admissions and discharges. In addition data 
from two of the three epilepsy centres in The 
Netherlands were included. We restricted this 
retrospective study to adult patients (older 
than 15 years).
During the period 1980-87 we gathered a 
total of 576 admissions caused by various 
types of SE. We visited every hospital and 
inspected the patient files.
For SPSE, only patients with preserved 
consciousness and with a minimum seizure 
duration of 30 minutes were included. 
Patients with hemi-grand mal SE, asymmetric 
generalised tonic-clonic SE, or patients with 
successive secondary generalised tonic-clonic 
seizures with persistent clonic jerks of one side 
of the body and impaired level of conscious­
ness were excluded.
When a single tonic-clonic seizure preceded 
or occurred at the end of the SPSE, the patient 
was included. Morbidity was defined as all 
new neurological signs occurring during the 
period of SE and was calculated per event. 
The causes of morbidity were classified as (a) 
the underlying cause, (Jb) the seizures them­
selves and the ensuing medical complications, 
and (c) unknown (when the contribution of 
the underlying cause or the seizures them­
selves could not exactly be established). The 
causes of mortality have been divided in the 
same way.
Outcome has been described as the neuro­
logical condition at discharge from the hospi­
tal.
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Treatment was regarded as inadequate 
when an insufficient dose was given, when the 
route of treatment was wrong (for example, 
intramuscular injection of diazepam), when 
unnecessary delay was present (for example, 
waiting for more than an hour after diazepam 
injection while the seizure continued before 
giving a second agent) , when mechanical venti­
lation was not started despite signs of respira­
tory failure or the presence of various other 
medical complications, or when EEG moni­
toring was not done on patients treated with 
antiepileptic drugs together with curarisation.
Results
The Netherlands has a population of nearly 15 
million people. About 100 000 have epilepsy. 
The admissions we retrieved covering a period 
of eight years concerned 47 patients; 27 were 
known to have a history of epilepsy. The 
causes of previous epilepsy were symptomatic 
in 18, whereas in nine patients the cause 
remained unknown. In five patients SPSE 
ended with a generalised tonic-clonic seizure,, 
in seven a tonic-clonic seizure preceded SPSE.
In our material a preponderance of 30 
women versus 17 men was found. There was 
an increase of SPSE with age. Only 16 of our 
patients were younger than 50; two were 
younger than 30.
TYPES OF SPSE
Apart from one patient with aphasic SE all 
showed somatomotor SPSE; four of these had 
adversive SPSE.
The facial musculature was involved in 38 
patients, alone (eight) or in combination with 
the eyes (one), an arm (seven), platysma 
(two), and an arm and a leg (20). In four 
patients jerking was limited to an arm (one), a 
hand (two), or the abdominal wall (one).
The patient with aphasic SPSE was a woman 
aged 67, known to have had previous epilepsy 
(caused by stroke), who developed SPSE with a 
duration of five days. The clinical presentation 
consisted of aphasia, acoustic hallucinations 
(strange sounds, music, voices), left sided 
headache, and visual hallucinations (red balls in 
the front of the right eye). She remained alert 
and showed recurrent epileptic seizures on the 
EEG, starting in the left occipital region with a 
13 Hz sharp wave activity, changing to spike 
wave activity (3-4 Hz), and spreading over the 
left hemisphere. Sometimes a start was seen in 
the left paracentral region. Further investiga­
tions could not establish a cause. When the 
EEG showed that the SPSE had been arrested 
the patient continued to exhibit persistent word 
finding problems and a slight verbal memory 
deficit.
In 26 of 46 patients with somatomotor 
SPSE, frank seizures were evident without doc­
umented continuous myoclonus. The remain­
ing 20, showed more or less continuous clonic 
or myoclonic jerks, corresponding to EPC. 
When we compared the patients with EPC with 
those without continuous myoclonus., no differ­
ences were found for outcome, number of 
patients with previous epilepsy, or causes.
During SPSE EEG investigation was made 
in only 13 patients and showed abnormal find­
ings corresponding to the clinical expression in 
12 of them. However, specific epileptic dis­
charges were present in only five patients. 
Brain CT was performed in all; MRI, PET, or 
SPECT in none.
CAUSES OF SPSE
In 27 patients with previous epilepsy six devel­
oped SPSE because of a new neurological 
problem: metastases (two), stroke (one), 
pneumococcal meningitis (one), osteomyelitis 
of the skull (one), and hypocalcaemia (one). 
Compliance problems (antiepileptic drugs) 
were only present in three patients. In three 
patients a systemic infection was considered to 
be the precipitating factor. In 15 patients the 
cause remained unknown.
In 20 patients without previous epilepsy 
stroke seemed the most prominent cause (14), 
In three patients a brain tumour had been 
found, whereas in another three patients a 
cause could not be established.
DURATION OF SPSE
Duration was less than two hours in 13 
patients, between two and four hours in 12  , 
between four and 20 hours in four, and longer 
than 20 hours in 18. Half of these had a dura­
tion of one to three days, the other half 
between three and 14 days. An exceptionally 
long duration (seven weeks or more than one 
year) was seen in three patients with continu­
ous focal myoclonic jerks (EPC).
O U TC O M E O F  SPSE
Four patients died, all due to cerebral infarc­
tion.
Morbidity after SPSE was present in 10 
patients and consisted of paresis (four), aphasia 
(two), psychiatric disturbance (one), cognitive 
impairment (two), and persistent impairment 
of consciousness (one). Morbidity was mainly 
due to the underlying cause (six patients); in 
three patients the exact cause of morbidity 
could not be established. In one patient mor­
bidity was attributed to SE itself.
In the six patients with sequelae because of 
the underlying cause, four had had a cerebral 
infarction, one a subdural haematoma, and 
one an intracerebral haematoma. The patients 
with sequelae of unknown cause had all had 
previous epilepsy.
TR EA TM EN T
The last treatment, given just before SPSE 
ended or given as a last attempt consisted 
mainly of benzodiazepines, in particular 
(40%) clonazepam or clonazepam with pheny- 
toin. Other drugs were intravenous phenytoin, 
diazepam, or lidocaine, etomidate infusion, 
thiopentone infusion, carbamazepine, and 
intravenous calcium in a case of hypocal­
caemia. In this last case calcium was immedi­
ately successful, whereas diazepam and 
clonazepam failed.
When outcome was related to quality of 
treatment we found in patients with good out­
come that treatment was inadequate in 2 1 %;
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in patients with morbidity in 40%, and in 
patients with fatal outcome in 50 %.
Discussion
The symptom SPSE is relatively rare and most 
case reports and reviews concern EPC, also 
named somatomotor SPSE.4 We did not find 
specific differences between patients with con­
tinuous clonic or myoclonic activity and 
patients with partial motor seizures for cause, 
outcome, and the presence of previous 
epilepsy. Our findings differ from those pub­
lished for the frequency of previous epilepsy in 
patients with SPSE. Duration of SPSE in our 
series was generally shorter than mentioned in 
the medical literature and we differ in having a 
higher prevalence of female patients.
The cause of SPSE in our 20 patients with­
out previous epilepsy was stroke in 70%, a 
brain tumour in 15%a and unknown in 
another 15%. Two of the latter patients had a 
chronic psychiatric disease and one a remote 
symptomatic cause (subarachnoid haemor­
rhage some years earlier).
In patients with previous epilepsy an acute 
neurological problem seemed to be a promi­
nent cause (22%).
No correlation could be established 
between outcome and duration. Outcome was 
mainly determined by the underlying cause. In 
three patients the cause of morbidity remained 
unknown. All three had previous epilepsy; one 
was suspected to have a brain lesion, but the 
exact nature was not known; another was 
mentally retarded and the third had epilepsy 
because of stroke and a new cerebrovascular 
accident was suggested but this could not be 
determined with certainty. Only in one case 
SPSE itself as a cause of morbidity was likely.
Continuing seizure activity as a cause of 
morbidity in PSE has been established in 
complex partial SE,9 and SPSE as a cause of 
morbidity has been suggested in some other 
patients.1011
In SPSE, as in GCSE 12 we found that treat­
ment was more often inadequate in patients 
with less good outcome, but the number of 
patients with mortality or morbidity was too 
low to draw conclusions.
Treatment of SE^ irrespective of type, 
should be according to protocol.13 We advise 
starting with rectal diazepam solution, 20-30 
mg in adult patients. When seizures persist for 
10 minutes after the diazepam give 1 mg clon­
azepam intravenously. Next the patient should 
be transferred to the intensive care unit 
because of the threat of respiratory depression. 
Continue with 1 mg clonazepam every one or 
two minutes intravenously until seizures stop 
or respiratory depression becomes evident. If 
clonazepam fails after 10 minutes, start pheny- 
toin-sodium intravenously (15-18 mg/kg with 
a rate of 50 mg/min). For those who continue 
with seizures start with midazolam-infusion at a 
rate of 0*3-0*6 mg/kg/24 h after a bolus injec- 
tion of 0* 1-0*3 mg/kg. We also have good 
results with propofol infusion. In most patients 
with SPSE thiopentone infusion is not neces­
sary.
During treatment adequate medical care 
with special attention to respiration is essen­
tial. The cause of SPSE should be established 
as soon as possible, maintenance treatment 
with antiepileptic drugs should be continued 
or started. In patients resistant to drug therapy 
surgical treatment may be considered.14
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